AirMed Labs: Financial Breakdown
Decoding financial health metrics of AirMed Labs
Total Revenue₹12.4 Cr41%Prev. FY
Total Expenses₹9.7 Cr27%Prev. FY
Profit After Tax₹2.1 Cr153%Prev. FY
Total Assets₹38.5 Cr87%Prev. FY
Net Profit Margin16.7%79%Prev. FY
FAQs on Financials of AirMed Labs
Yes. In FY25, AirMed Labs reported a profit after tax of ₹2.1 Cr, making it profitable.
AirMed Labs's revenue grew 41.8% year-on-year, from ₹8.7 Cr in FY24 to ₹12.4 Cr in FY25.
AirMed Labs's estimated EBITDA for FY25 was ₹7.4 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, AirMed Labs posted revenue of ₹12.4 Cr (up 41.8% YoY) and a profit after tax of ₹2.1 Cr. Explore the full financials of AirMed Labs here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links